ADIA Nutrition Inc. (OTCQB: ADIA), today announced that its subsidiary, Adia Med of Winter Park, LLC., has officially begun ...

Rakuten Medical, a developer of cancer treatments partly owned by Japan’s Rakuten Group, completed a fundraising round as it ...

The 2025 American Society of Hematology (ASH) meeting in December presented a clear message: scientific innovation and ...

Aligned with U.S. Food and Drug Administration (FDA) on Registrational Path for RE104 in Postpartum Depression (PPD); On Track to Initiate ...

EMA approval decision for obicetrapib and obicetrapib/ezetimibe fixed dose combo expected in 2H26 ---- Phase 3 PREVAIL CVOT overall event rate ...

Scientists at USC are launching a new trial to test a tiny stem cell implant that could restore vision in people with ...

Long COVID affects an estimated 65 million people worldwide and can damage the brain, heart, blood vessels, and immune system ...

We spoke with Scott Jones, PhD, SVP & CSO at BioBridge Global (BBG) to understand the challenges of product-specific potency ...

A clinical-stage biotechnology company headquartered in Palo Alto, California. The company is focused on respiratory medicine ...

Your Year of Miracles opens 2026 enrollment for a year-long online mentoring program, plus a new free ebook and ...

Megestrol, which helps treat hot flashes associated with menopause, may have the added benefit of slowing the growth of ...

-- Proceeds to drive global Phase 3 trial for ASP-1929, targeting BLA submission to the U.S. FDA in 2028 -- Financing led by international life science fund TaiAx, with participation from the largest ...